Search Results - "Sahafi, Flora"
-
1
Phenotypic Characterization of the Immune Landscape in the Bone Marrow of Patients with Acute Myeloid Leukemia (AML) Using MultiOmyxTM Hyperplexed Immunofluorescence Assay
Published in Blood (13-11-2019)“…Background: Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disorder. Bone marrow (BM) constitutes the home niche for leukemia cells…”
Get full text
Journal Article -
2
Abstract 408: Reduction of tumor-infiltrating B cells linked to recurrence of NSCLC tumors
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Introduction: Lung cancer is the leading cause of cancer related mortality worldwide. Non-small cell lung cancer (NSCLC), accounting for approximately…”
Get full text
Journal Article -
3
Abstract 2092: Tumor-infiltrating myeloid cells: Using MultiOmyx to distinguish between TAMs, TANs, and MDSCs in the pancreatic tumor microenvironment
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Myeloid cells are the primary recruited effector cells during inflammation. A subset of these, consisting primarily of tumor-associated M1/M2…”
Get full text
Journal Article -
4
Characterization of Immunosuppressive Cells Using MultiOmyx in Hematological Malignancies
Published in Annals of oncology (01-10-2019)Get full text
Journal Article -
5
MO3-13-6 [Encore]Characterization of Immunosuppressive Cells Using MultiOmyx in Hematological Malignancies
Published in Annals of oncology (01-10-2019)“…Abstract Background Tumor associated macrophages (TAM) and myeloid-derived suppressor cells (MDSC) can assist tumors to escape immune surveillance within the…”
Get full text
Journal Article -
6
Abstract 497: Characterization of TIGIT expression using MultiOmyxTM hyperplexed immunofluorescence assay in solid tumors
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract TIGIT (T cell immunoreceptor with Ig and ITIM domains) is a recently identified immune-receptor that is expressed on T cells, natural killer (NK)…”
Get full text
Journal Article -
7
Abstract 1175: A pro-tumorigenic mechanism of M2 tumor-associated macrophages in triple-negative breast cancer
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract Introduction: Triple-negative breast cancers (TNBCs) are defined as tumors that are negative for both estrogen, progesterone and HER-2 receptors. It…”
Get full text
Journal Article -
8
Using a multiplexed immunofluorescence approach to compare immune cell populations in subtypes of non-small cell lung cancer
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e20702 Background: Non-small cell lung cancer (NSCLC) accounts for approximately 80-85% of all lung cancer cases, and is characterized by a poor…”
Get full text
Journal Article -
9
Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyxTM Hyperplexed Immunofluorescence Assay in Hodgkin Lymphoma
Published in Blood (29-11-2018)“…Tumor microenvironment (TME) consists of heterogeneous subsets of myeloid cells and plays a crucial role in promoting cancer development and metastasis. Tumor…”
Get full text
Journal Article -
10
Abstract 94: Interrogation of STING induced cytokines in the tumor microenvironment using an Integrated MultiOmyx-RNAscope panel for spatial and quantitative profiling
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract The STING (Stimulator of Interferon Genes) pathway is a pivotal player in the innate immune response, responsible for detecting cytosolic accumulation…”
Get full text
Journal Article -
11
Abstract 4578: Quantification of protein complexes and post-translational modifications in colorectal cancer utilizing combinted MultiOmyxTM and PLA assay from a single FFPE slide
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract A comprehensive signaling pathway analysis is critical to characterize cancer pathogenesis, in which malignant cells evolve from nonmalignant cells,…”
Get full text
Journal Article -
12
Abstract 4688: Comprehensive analysis of natural killer cell-associated markers using MultiOmyxTM immunofluorescence assay
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have recently gained attention as an important type of…”
Get full text
Journal Article -
13
Abstract 4696: Characterizing CD39 and CD73 cell subtypes in the tumor microenvironment using MultiOmyx
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract CD39 and CD73 are membrane bound enzymes that function together to convert extracellular adenosine 5’-triphospate (ATP)/adenosine diphosphate (ADP)…”
Get full text
Journal Article -
14
Abstract 5487: Improved spatial biology analysis of the tumor microenvironment with the next generation of the MultiOmyxTMplatform
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Multiplexed Immunofluorescence is a powerful tool for spatially characterizing and phenotyping cells within the tumor microenvironment. MultiOmyx has…”
Get full text
Journal Article -
15
Abstract 1705: Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyx࣪ assay
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Immune checkpoint blockade (ICB) therapy has revolutionized the landscape of cancer therapy in multiple tumor types since Ipilimumab, the first ICB…”
Get full text
Journal Article